Literature DB >> 32046835

Streamlining Hospital Treatment of Prosthetic Joint Infection.

Kevin M Goodson1, James R Kee1, Paul K Edwards1, Amanda J Novack2, Jeffrey B Stambough1, Eric R Siegel3, C Lowry Barnes1, Simon C Mears1.   

Abstract

BACKGROUND: Prosthetic joint infection (PJI) is associated with significant morbidity, mortality, and costs. We developed a fast-track PJI care system using an infectious disease physician to work directly with the TJA service and coordinate in the treatment of PJI patients. We hypothesized that streamlined care of patients with hip and knee PJI decreases the length of the acute hospital stay without increasing the risk of complication or incorrect antibiotic selection.
METHODS: A single-center retrospective chart review was performed for all patients treated operatively for PJI. A cohort of 78 fast-track patients was compared to 68 control patients treated before the implementation of the program. Hospital length of stay (LOS) and cases of antibiotic mismatch were primary outcomes. Secondary outcomes, including 90-day readmissions, reoperations, mortality, rate of reimplantation, and 12-month reimplant survival, were compared. Cox regressions were analyzed to assess the effects on LOS of patient demographics and the type of surgery performed.
RESULTS: Average hospital LOS from infection surgery to discharge was significantly lower in the fast-track cohort (3.8 vs 5.7 days; P = .012). There were no episodes of antibiotic mismatch in the fast-track group vs 1 recorded episode in the control group. No significant differences were noted comparing 90-day complications, reimplantation rate, or 12-month reimplant survival rates.
CONCLUSION: Through the utilization of an orthopedic-specific infectious disease physician, a fast-track PJI protocol can significantly shorten hospital LOS while remaining safe. Streamlining care pathways may help decrease the overall healthcare costs associated with treating PJI.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antibiotic mismatch; fast-track; infectious disease physician; length of stay; prosthetic joint infection

Year:  2020        PMID: 32046835     DOI: 10.1016/j.arth.2019.10.056

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  Serum antibodies against Staphylococcus aureus can prognose treatment success in patients with bone infections.

Authors:  Gowrishankar Muthukrishnan; Christopher A Beck; John R Owen; Chao Xie; Stephen L Kates; John L Daiss
Journal:  J Orthop Res       Date:  2020-12-25       Impact factor: 3.102

2.  Humanized Mice Exhibit Exacerbated Abscess Formation and Osteolysis During the Establishment of Implant-Associated Staphylococcus aureus Osteomyelitis.

Authors:  Gowrishankar Muthukrishnan; Alexandra Wallimann; Javier Rangel-Moreno; Karen L de Mesy Bentley; Maria Hildebrand; Karen Mys; H Mark Kenney; Eric T Sumrall; John L Daiss; Stephan Zeiter; R Geoff Richards; Edward M Schwarz; T Fintan Moriarty
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

3.  IgG4-specific responses in patients with Staphylococcus aureus bone infections are not predictive of postoperative complications.

Authors:  J R Owen; M P Campbell; M D Mott; C A Beck; C Xie; G Muthukrishnan; J L Daiss; E M Schwarz; S L Kates
Journal:  Eur Cell Mater       Date:  2021-09-22       Impact factor: 3.942

4.  Systemic IL-27 administration prevents abscess formation and osteolysis via local neutrophil recruitment and activation.

Authors:  Yugo Morita; Motoo Saito; Javier Rangel-Moreno; Anthony M Franchini; John R Owen; John C Martinez; John L Daiss; Karen L de Mesy Bentley; Stephen L Kates; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Bone Res       Date:  2022-08-26       Impact factor: 13.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.